Efren J. Flores

Efren J. Flores

Auto-generated profile, based on publicly available information

Efren J. Flores

Department of Radiology, Massachusetts General Hospital, Boston, MA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2020 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
MLMin Lang
Min Lang
ASAvik Som
Avik Som
DMDexter P Mendoza
Dexter P Mendoza
EFEfren J Flores
Efren J Flores
NRNicholas Reid
Nicholas Reid
BLBrent P Little
Brent P Little

1 February 2019 in Radiology
Verified
Journal Article
Closed access
GWGary X. Wang
Gary X. Wang
TBTravis P. Baggett
Travis P. Baggett
PPPari V. Pandharipande
Pari V. Pandharipande
EPElyse R. Park
Elyse R. Park
SPSanja Percac-Lima
Sanja Percac-Lima
EFEfren J. Flores
Efren J. Flores
Awareness of the many current challenges faced by patients and referring providers will empower radiologists to continue to collaboratively guide nationwide multidisciplinary efforts to broadly and equitably implement lung cancer screening. Lung cancer remains the leading cause of cancer mortality in the United States. Lung cancer screening (LCS) with low-dose CT reduces mortality among high-risk current and former smokers and has been covered by public and private insurers without cost sharing since 2015. Patients and referring providers confront numerous barriers to participation in screening. To best serve in multidisciplinary efforts to expand LCS nationwide, radiologists must be knowledgeable of these challenges. A better understanding of the difficulties confronted by other stakeholders will help radiologists continue to collaboratively guide the growth of LCS programs in their communities. This article reviews barriers to participation in LCS for patients and referring providers, as well as possible solutions and interventions currently underway. © RSNA, 2019

1 June 2020 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
Min LangMin Lang
Min Lang
ASAvik Som
Avik Som
DCDenston Carey
Denston Carey
NRNicholas Reid
Nicholas Reid
DMDexter P. Mendoza
Dexter P. Mendoza
BLBrent P. Little
Brent P. Little
Background Parenchymal findings in COVID-19 pneumonia on computed tomography (CT) have been well characterized. However, the role of pulmonary vascular pathology in COVID-19 pneumonia is still not ...

1 October 2017 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
HHH. Benjamin Harvey
H. Benjamin Harvey
CLCatherine Liu
Catherine Liu
JAJing Ai
Jing Ai
CJCristina Jaworsky
Cristina Jaworsky
CGClaude Emmanuel Guerrier
Claude Emmanuel Guerrier
OPOleg Pianykh
Oleg Pianykh

1 November 2015 in RadioGraphics
Verified
Journal Article
Closed access
FFFlorian J Fintelmann
Florian J Fintelmann
ABAdam Bernheim
Adam Bernheim
SDSubba R. Digumarthy
Subba R. Digumarthy
ILInga T. Lennes
Inga T. Lennes
MKMannudeep K. Kalra
Mannudeep K. Kalra
JSJo-Anne O. Shepard
Jo-Anne O. Shepard
The authors review the rationale for lung cancer screening and the 10-pillar model required to start an effective lung cancer screening program. On the basis of the National Lung Screening Trial data released in 2011, the U.S. Preventive Services Task Force made lung cancer screening (LCS) with low-dose computed tomography (CT) a public health recommendation in 2013. The Centers for Medicare and Medicaid Services (CMS) currently reimburse LCS for asymptomatic individuals aged 55–77 years who have a tobacco smoking history of at least 30 pack-years and who are either currently smoking or had quit less than 15 years earlier. Commercial insurers reimburse the cost of LCS for individuals aged 55–80 years with the same smoking history. Effective care for the millions of Americans who qualify for LCS requires an organized step-wise approach. The 10-pillar model reflects the elements required to support a successful LCS program: eligibility, education, examination ordering, image acquisition, image review, communication, referral network, quality improvement, reimbursement, and research frontiers. Examination ordering can be coupled with decision support...

1 January 2016 in RadioGraphics
Verified
Journal Article
Closed access
AOAlexi Otrakji
Alexi Otrakji
SDSubba R. Digumarthy
Subba R. Digumarthy
RGRoberto Lo Gullo
Roberto Lo Gullo
EFEfren J. Flores
Efren J. Flores
JSJo-Anne O. Shepard
Jo-Anne O. Shepard
MKMannudeep K. Kalra
Mannudeep K. Kalra
Dual-energy CT of the chest can provide additional information on several pulmonary and mediastinal abnormalities compared with single-energy CT. Recent studies have demonstrated that dual-energy computed tomography (CT) can provide useful information in several chest-related clinical indications. Compared with single-energy CT, dual-energy CT of the chest is feasible with the use of a radiation-dose-neutral scanning protocol. This article highlights the different types of images that can be generated by using dual-energy CT protocols such as virtual monochromatic, virtual unenhanced (ie, water), and pulmonary blood volume (ie, iodine) images. The physical basis of dual-energy CT and material decomposition are explained. The advantages of the use of virtual low-monochromatic images include reduced volume of intravenous contrast material and improved contrast resolution of images. The use of virtual high-monochromatic images can reduce beam hardening and contrast streak artifacts. The pulmonary blood volume images can help differentiate various parenchymal abnormalities, such as infarcts, atelectasis, and pneumonias, as well as airway abnormalities....